Skip to main content

Table 1 Characteristics of HPV negative versus HPV positive patients

From: Prognostic role of HPV infection in esophageal squamous cell carcinoma

Variable HPV negative HPV positive
(n = 60) no. (%) (n = 14) no. (%)
Age at diagnosis ≤ 60 29 (48.3%) 4 (28.6%)
>  60 31 (51.7%) 10 (71.4%)
Gender Female 10 (16.7%) 6 (42.9%)
Male 50 (83.3%) 8 (57.1%)
Tumor location Upper third 8 (13.3%) 4 (28.6%)
Middle third 35 (58.3%) 6 (42.8%)
Lower third 17 (28.4%) 4 (28.6%)
Clinical T stage cT3 26 (43.3%) 8 (57.1%)
cT4 34 (56.7%) 6 (42.9%)
Clinical N stage cN0 6 (10.0%) 4 (28.6%)
cN1–2 54 (90.0%) 10 (71.4%)
Clinical M stage cM0 49 (81.7%) 14 (100.0%)
cM1 11 (18.3%) 0 (0.0%)